Literature DB >> 9799097

The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain.

F Letzelter1, Y Wang, W Sebald.   

Abstract

Human IL-4 (IL-4), one of the small four-helix-bundle cytokines, uses the specific IL-4 receptor a chain together with a promiscuous subunit, the common gamma chain (gamma(c)) for transmembrane signaling. The ligand-binding properties of gamma(c), which are presently poorly understood, were analysed by biosensor techniques employing recombinant ectodomains of gamma(c) and a receptor chains (IL4-BP). The formation of a ternary complex between solute gamma(c) ectodomain and IL-4 saturated IL4-BP could be established to exhibit a high dissociation constant Kd = 3 microM and a short half life tau1/2 = 7 s. This binding affinity resulted to the major part from the interaction of gamma(c) ectodomain with IL-4 and not from a direct contact of the ectodomains, since binding between solute gamma(c) ectodomain and IL-4 could be established (Kd about 150 microM), whereas no binding was found between the gamma(c) ectodomain and IL4-BP in the absence of IL-4. The IL-4 epitope involved in gamma(c) ectodomain interaction (site 2) was identified by means of an alanine-scanning mutational approach. The IL-4 site 2 comprised residues I11 and N15 on helix A together with Y124 on helix D as major binding determinants. The IL-4 alanine variants at site 2 generally showed only moderate defects in biological activity. Even the most affected variant [A124]IL-4 retained a partial agonist activity of about 50% during a T-cell proliferation assay. The dosis leading to a half-maximal response (EC50) was not altered by site-2 substitutions. The present results are in accordance with a two-step-dimerisation mechanism for IL-4 receptor activation, where solute IL-4 at physiological concentrations binds first via the high-affinity site 1 to the a chain only, since the affinity of IL-4 site 2 for gamma(c) is too low. This site-2 affinity seems to be sufficient, however, to promote, in a second step, a productive association of gamma(c) to an IL-4/alpha chain complex in the membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799097     DOI: 10.1046/j.1432-1327.1998.2570011.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection.

Authors:  Martynas Gavutis; Suman Lata; Peter Lamken; Pia Müller; Jacob Piehler
Journal:  Biophys J       Date:  2005-03-18       Impact factor: 4.033

2.  De novo design of an IL-4 antagonist and its structure at 1.9 A.

Authors:  Sherry L Laporte; Charles M Forsyth; Brian C Cunningham; Larry J Miercke; David Akhavan; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

3.  Rationalizing 5000-fold differences in receptor-binding rate constants of four cytokines.

Authors:  Xiaodong Pang; Sanbo Qin; Huan-Xiang Zhou
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

4.  IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma.

Authors:  Tohru Hosoyama; Mohammed Imran Aslam; Jinu Abraham; Suresh I Prajapati; Koichi Nishijo; Joel E Michalek; Lee Ann Zarzabal; Laura D Nelon; Denis C Guttridge; Brian P Rubin; Charles Keller
Journal:  Clin Cancer Res       Date:  2011-05-01       Impact factor: 12.531

Review 5.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

6.  Rational design of interleukin-21 antagonist through selective elimination of the gammaC binding epitope.

Authors:  Lishan Kang; Kent Bondensgaard; Tengkun Li; Rune Hartmann; Siv A Hjorth
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

7.  Structural and biophysical studies of the human IL-7/IL-7Ralpha complex.

Authors:  Craig A McElroy; Julie A Dohm; Scott T R Walsh
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

Review 8.  Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway.

Authors:  Scott T R Walsh
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

9.  Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis.

Authors:  Masooma Sultani; Andrea M Stringer; Joanne M Bowen; Rachel J Gibson
Journal:  Chemother Res Pract       Date:  2012-09-02

Review 10.  Insights into cytokine-receptor interactions from cytokine engineering.

Authors:  Jamie B Spangler; Ignacio Moraga; Juan L Mendoza; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.